Ticker: LFST

LifeStance Health Group, Inc. (NASDAQ: LFST) recently released its quarterly report for the period ending March 31, 2025, showcasing a moderate revenue growth while addressing a few operational challenges. Positive Aspects: Total Revenue: Increased by 11% to $332.97 million from $300.44 million ...

LifeStance Health (NASDAQ: LFST) reports Q2 2024 revenue up 20% to $312M and adjusted EBITDA of $29M. The company enhances its full-year outlook, driven by a hybrid care model and a growing clinician network. Profitability remains elusive amid ongoing investments.